This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Nursing home chain Consulate Health Care is staring down the prospect of paying $331 million after a jury found the company illegally upcoded Medicare therapy claims (United States ex rel. Ruckh v. CMCII, LLC, M.D. Fla., No. 11-cv-1303, judgment 3/1/17; United States ex rel. Ruckh v. CMCII, LLC, M.D. Fla., No. 11-cv-1303, judgment 3/1/17).
Consulate’s counsel told Bloomberg BNA on March 2 that the company would urge Judge Steven D. Merryday to set aside the jury’s verdict, and resulting damages award, however. Consulate’s motion is due before the end of March, and health-care providers and attorneys are anxious to see whether Merryday will allow a rare False Claim Act jury verdict and award to stand.
The huge money damages are a product of the FCA’s provision that mandates a tripling of the losses suffered by government programs like Medicare and Medicaid from a defendant’s wrongful conduct.
This sort of judicial back peddling isn’t unheard of in litigation in general, or FCA litigation in particular. A similar situation played out in a federal court in Alabama when a district judge granted a hospice provider summary judgment on FCA allegations in a March 2016 ruling after a jury returned a verdict finding that the defendant, AseraCare Inc., submitted false claims.
Merryday did express skepticism at whistle-blower Angela Ruckh’s purported evidence of improper upcoding of Medicare claims for therapy services in a Dec. 1, order, despite the jury’s apparent acceptance of the evidence as enough to find 446 individual FCA violations.
While the AseraCare verdict did show that a federal judge can decide after a verdict that a jury was perhaps too eager to assign legal violations to Medicare claim submissions, the federal judge in the AseraCare litigation set aside the jury’s verdict by granting summary judgment to the hospice provider. Merryday’s Dec. 1 order, only a couple of months before the start of trial, specifically rejected Consulate’s motion for summary judgment, perhaps making the AseraCare precedent less likely for a repeat result.
Read more about the Consulate Health Care FCA litigation in my story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to books@bna.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to research@bna.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)